Brown R C, Aston J P, St John A, Woodhead J S
Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff.
J Immunol Methods. 1988 Apr 22;109(1):139-44. doi: 10.1016/0022-1759(88)90451-6.
We have evaluated the potential of monoclonal antibodies in the development of a non-isotopic immunometric assay for intact human parathyroid hormone (PTH). The assay has been designed to utilise a chemiluminescent acridinium ester labelled anti-aminoterminal (anti-N) antibody and a solid-phase anti-carboxyterminal antibody in order to measure specifically the intact hormone. In this system the characteristics of the labelled antibody proved crucial to the performance of the assay. A low affinity monoclonal reagent yielded insufficient analytical sensitivity, while a higher affinity monoclonal reagent cross-reacted poorly with the intact molecule relative to the amino terminal PTH fragment to which it was raised. Neither antibody could therefore match the performance of an affinity-purified polyclonal anti-N PTH reagent. These results highlight the problems to be addressed in the selection of suitable reagents for immunometric assay development when specificity and sensitivity are crucial requirements.
我们评估了单克隆抗体在开发用于完整人甲状旁腺激素(PTH)的非同位素免疫测定法中的潜力。该测定法旨在利用化学发光吖啶酯标记的抗氨基末端(抗N)抗体和固相抗羧基末端抗体,以特异性测量完整激素。在该系统中,标记抗体的特性被证明对测定性能至关重要。低亲和力的单克隆试剂产生的分析灵敏度不足,而高亲和力的单克隆试剂与完整分子的交叉反应相对于其针对的氨基末端PTH片段较差。因此,两种抗体都无法与亲和纯化的多克隆抗N PTH试剂的性能相匹配。这些结果突出了在特异性和灵敏度是关键要求时,为免疫测定法开发选择合适试剂时需要解决的问题。